Use of the Dysphagia Handicap Index (DHI) patient reported outcomes measure in Parkinson disease and cervical dystonia
Objective: Objective: To demonstrate the value of using the DHI in movement disorders clinics. Background: Background: Dysphagia has a negative effect on work, leisure, and…Correlation of Functional Motor Assessments Used at Parkinson’s disease by Physiotherapists in Clinical Practice
Objective: The aim of this study was to verify whether there is a correlation between UPDRS motor score and non-specific assessments for PD commonly used…Subacute Encephalopathy with Seizures in Alcohol Consumers (SESA) presenting as Focal Dyskinesias and Myoclonus
Objective: The purpose of this case series is to describe the clinical and electrophysiological features of SESA syndrome presenting as focal seizures mimicking dyskinesias and…Extent of cognitive impairment in Parkinson`s disease with Covid-19
Objective: To study of the extent of cognitive impairment in PD patients with Covid-19. Background: Covid-19 may aggravate the clinical course of Parkinson's disease (PD)…Fragile X Related Tremor in FMR1 Premutation Women without FXTAS
Objective: To determine whether there is a FMR1 premutation associated tremor in women who do not meet criteria for Fragile X-associated tremor ataxia syndrome (FXTAS)…Correlation between hemoglobin level and disease severity in patients with Parkinson’s disease
Objective: Objective of this study was to investigate the potential correlation between hemoglobin levels and Parkinson's disease (PD) severity, and to compare them with a…Hypothalamic involvement in Multiple System Atrophy: a clinical and neuroimaging study
Objective: To investigate hypothalamic atrophy and its clinical correlates in Multiple System Atrophy (MSA) through MRI. Background: MSA is characterized by autonomic dysfunction, i.e. orthostatic…Positive and negative myoclonus monitoring using ambulatory surface EMG and 3D accelerometry
Objective: An objective method is presented for monitoring of positive and negative myoclonus using wearable surface EMG and 3D accelerometry in clinical and home settings.…The neuroprotective properties of NLX-112 in MPTP treated mice are mediated by reactive gliosis and astrocytic GDNF
Objective: To investigate whether NLX-112, a potent and selective 5-HT1A agonist is neuroprotective in a mouse MPTP model of Parkinson’s Disease (PD) [1]. Background: There…Investigation of usefulness of new MSA diagnostic criteria
Objective: We investigated the utility of the Movement Disorder Society Criteria (MDS criteria) including sensitivity and specificity. Background: Multiple system atrophy (MSA) is an adult-onset…
- « Previous Page
- 1
- …
- 212
- 213
- 214
- 215
- 216
- …
- 1554
- Next Page »